1.   Mengting Wang#,Yaxin Liu#, Bin Shao, Xiaoran Liu, Zhiyuan Hu, Chen Wang, Huiping Li*,Ling Zhu*, Ping Li* and Yanlian Yang*,” HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment”, Frontiers in Bioengineering and Biotechnology,2022,10,1015295,DOI: 10.3389/fbioe.2022.1015295

2.    Wenbo Zhang, Mingwei Liu, Lanlan Yu, Shanshan Mo, Zhun Deng, Shuli Liu, Yanlian Yang, Chen Wang, Chenxuan Wang*, “ Perturbation effect of single polar group substitution on the Self-Association of amphiphilic peptide helices”, Journal of Colloid and Interface Science, 2022,610,1005-1014, DOI: 10.1016/j.jcis.2021.11.154

3.    Rong Du, Chen Wang, Ling Zhu *, Yanlian Yang*, “Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges”, Pharmaceutics, 2022,14,2236, DOI: 10.3390/pharmaceutics14102236

4.    王嘉莉,　朱凌,　王琛*,　雷圣宾*,　杨延莲*, “循环肿瘤细胞及细胞外囊泡的纳米检测技术”,化学进展，2022,34,178-197， DOI: 10.7536/PC210346

5.   Shuya Song, Ling Zhu*, Chen Wang*, Yanlian Yang*, “ In vitro diagnostic technologies for the detection of extracellular vesicles: current status and future directions”, View, 2022,,20220011, DOI: 10.1002/VIW.20220011

6.    Siyuan Ye, Qing You, Shuya Song, Huayi Wang, Chen Wang*, Ling Zhu*, Yanlian Yang*, , “Nanostructures and Nanotechnologies for the Detection of Extracellular Vesicle”, Advanced Biology, 2022, e2200201, DOI: 10.1002/adbi.202200201

7.    Mengfei Xue#, Siyuan Ye#, Xiaopeng Ma, Fangfu Ye, Chen Wang, Ling Zhu, * Yanlian Yang,* Jianing Chen,*,“Single-Vesicle Infrared Nanoscopy for Noninvasive Tumor Malignancy Diagnosis”, Journal of the American Chemical Society,2022,144,,20278-20287, DOI: 10.1021/jacs.2c07393

8.    Shilin Xu, Meichen Zhang, Xiaocui Fang, Xuechun Hu, Haiyan Xing, Yanlian Yang, Jie Meng, Tao Wen, Jian Liu, Jianxiang Wang, Chen Wang, Haiyan Xu, “CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia”, ACS Applied Materials & Interfaces, 2022,14,38584-38593, DOI: 10.1021/acsami.2c11538

9.    Yang Song#, Yadong Wang#, Ai Guan, Jianchao Xue, Bowen Li, Zhicheng Huang, Zhibo Zheng, Naixin Liang*, Yanlian Yang* and Shanqing Li, “Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation”, Frontiers in Bioengineering and Biotechnology, 2023, 11, 1132940.DOI: 10.3389/fbioe.2023.1132940

10.         Ying Zhou, Jinmei Zhou, Jinyi Xiao, Yuehua Wang, Hao Wang, Haoyuan Shi, Chunyan Yue, Fei Jia, Ping Li, Zhiyuan Hu* , Yanlian Yang*, Zefei Jiang* and Tao Wang*, “Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy”, Frontiers in Oncology, 2022,12,866293, DOI: 10.3389/fonc.2022.866293  

11.          Zihan Wang#, Wei Xu#, Yanlian Yang#, Guoxuan Gao,Changsheng Teng, Zhicheng Ge, Huiming Zhang,Zhu Yuan, Guoqian Ding, Yang Wang, Peixin Li, Yaqian Xu,Ping Li, Zhiyuan Hu, Zhongtao Zhang* and Xiang Qu*, “Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer”, Frontiers in Oncology, 2022, 12:1006909.DOI: 10.3389/fonc.2022.1006909

12.   Jinmei Zhou#, Jiangling Wu#, Xiaopeng Hao#, Ping Li, Huiqiang Zhang, Xuexue Wu, Jiaxin Chen, Jiawei Liu, Jinyi Xiao, Shaohua Zhang, Zefei Jiang, Yanlian Yang, Zhiyuan Hu* and Tao Wang*, “An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer” Frontiers in Oncology, 2022, 12:966624.DOI: 10.3389/fonc.2022.966624

13.   Qing You, Fang Wang, Rong Du, Jingnan Pi, Huayi Wang, Yue Huo, Jingyi Liu, Chen Wang, Jia Yu,* Yanlian Yang,* and Ling Zhu*, “m6A Reader YTHDF1-Targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy via Epigenetic and Immune Regulation”, Advanced Materials, 2022, 2204910, DOI:10.1002/adma.202204910

14.   Mei Jiang#, Xiaocui Fang#, Lilusi Ma, Mingpeng Liu Mengting Chen, Jingyi Liu, Yanlian Yang*, Chen Wang* “A nucleus-targeting peptide antagonist towards EZH2 displays therapeutic efficacy for lung cancer”, International Journal of Pharmaceutics, 2022,622,121894, DOI: 10.1016/j.ijpharm.2022.121894

15.   Hao Li, Zihao Wang, Xiaocui Fang, Wenfeng Zeng, Yanlian Yang, Lingtao Jin, Xiuli Wei, Yan Qin, Chen Wang,* and Wei Liang,*,“Poroptosis: A form of cell death depending on plasma membrane nanopores formation”, iScience, 2022, 25(6), 104481, DOI: 10.1016/j.isci.2022.104481

16.    Pengyu Wang#, Xiaocui Fang#, Rong Du, Jiali Wang, Mingpeng Liu, Peng Xu, Shiqi Li, Kaiyue Zhang, Siyuan Ye, Qing You, Yanlian Yang,* and Chen Wang*, “Principles of Amino-Acid-Nucleotide Interactions Revealed by Binding Affinities between Homogeneous Oligopeptides and Single-Stranded DNA Molecules”, ChemBioChem, 2022, 23, e202200048, DOI: 10.1002/cbic.202200048

17.    Wenzhe Li, Ling Zhu, Kaidi Li, Siyuan Ye, Huayi Wang, Yadong Wang, Jianchao Xue, Chen Wang, Shanqing Li, Naixin Liang,* and Yanlian Yang*, “Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer”, nanomaterials, 2022.12,809, DOI: 10.3390/nano12050809

18.    宋诗洁、朱凌、王琛*、杨延莲*，“阿尔茨海默病体外诊断纳米技术”, 生物化学与生物物理进展，2022,49(1):72~85, DOI:：10.16476/j.pibb.2021.0296